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Summary
Cryptococcus neoformans is a facultative intracellular pathogen. The most distinctive feature of C. 
neoformans is a polysaccharide capsule that enlarges depending on environmental stimuli. The 
mechanism by which C. neoformans avoids killing during phagocytosis is unknown. We 
hypothesized that capsule growth conferred resistance to microbicidal molecules produced by the 
host during infection, particularly during phagocytosis. We observed that capsule enlargement 
conferred resistance to reactive oxygen species produced by H2O2 that was not associated with a 
higher catalase activity, suggesting a new function for the capsule as a scavenger of reactive 
oxidative intermediates. Soluble capsular polysaccharide protected C. neoformans and 
Saccharomyces cerevisiae from killing by H2O2. Acapsular mutants had higher susceptibility to 
free radicals. Capsular polysaccharide acted as an antioxidant in the nitroblue tetrazolium (NBT) 
reduction coupled to β-nicotinamide adenine dinucleotide (NADH)/phenazine methosulfate (PMS) 
assay. Capsule enlargement conferred resistance to antimicrobial peptides and the antifungal drug 
Amphotericin B. Interestingly, the capsule had no effect on susceptibility to azoles and increased 
susceptibility to fluconazole. Capsule enlargement reduced phagocytosis by environmental 
predators, although we also noticed that in this system, starvation of C. neoformans cells produced 
resistance to phagocytosis. Our results suggest that capsular enlargement is a mechanism that 
enhances C. neoformans survival when ingested by phagocytic cells.
Introduction
Cryptococcus neoformans is unique among pathogenic fungi because its cell body is 
surrounded by a polysaccharide capsule. The incidence of cryptococcosis has risen steadily 
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during the past century because of the increasing number of immunocompromised patients. 
In addition to its clinical importance, C. neoformans has become a major model system for 
studying fungal infections. C. neoformans is both a pathogenic and an environmental 
fungus, and has the ability to infect many different hosts, including amoebas, slime molds, 
worms, insects and mammals (Casadevall and Perfect, 1998; Steenbergen et al., 2001; 
Mylonakis et al., 2002; Apidianakis et al., 2004). C. neoformans is a facultative intracellular 
pathogen that can survive and divide inside phagocytic cells, indicating that this yeast has 
developed mechanisms to evade intracellular killing in the phagolysosome (Tucker and 
Casadevall, 2002; Alvarez and Casadevall, 2006). The capacity for intracellular 
pathogenesis is an important feature, because phagocytic cells such as macrophages and 
neutrophils constitute the first line of defence against many fungal pathogens. In this sense, 
differences in macrophage activity have been related to the differential susceptibility to C. 
neoformans of different species (Shao et al., 2005). However, some recent findings suggest 
that the ability of C. neoformans to exploit macrophages is a mechanism that allows fungal 
dissemination in the host (Kechichian et al., 2007; Zaragoza et al., 2007).
One of the peculiarities of C. neoformans is that, in contrast to many fungal pathogens, it 
possesses well-defined virulence factors. Among them, the polysaccharide capsule 
contributes most to the overall virulence phenotype (McClelland et al., 2006). The 
cryptococcal polysaccharide capsule is believed to protect against environmental stresses, 
such as dehydration and other stress conditions (Aksenov et al., 1973; Casadevall and 
Perfect, 1998). In addition to surrounding the cell, the capsular polysaccharide is also 
released and secreted to the extracellular environment and this material is referred as 
exopolysaccharide. During infection, the exopolysaccharide has numerous deleterious 
effects on the host immune response (see review in Vecchiarelli, 2000).
An important feature of the capsule is that it can dramatically change in size in response to 
environmental conditions. In regular laboratory conditions that often involve growth in rich 
media, the capsule is usually small. However, a variety of media that induce capsule growth 
have been described (Granger et al., 1985; Vartivarian et al., 1993; Zaragoza et al., 2003a; 
Zaragoza and Casadevall, 2004). In vivo, C. neoformans infection is associated with massive 
capsule enlargement and the phenomenon seems to be important for virulence. In fact, 
capsule enlargement is an early morphological change that occurs during the first hours of 
infection in mice. The capsule also enlarges in size in vitro during the interaction with 
phagocytic cells (Feldmesser et al., 2001). Granger et al. (1985) reported that a mutant that 
could not enlarge the capsule in the presence of CO2 showed reduced virulence, and this has 
been also confirmed with other type of mutants (D’Souza et al., 2001). Although this 
morphological change is characteristic during the interaction with the host, its function 
remains unclear. So far, capsule enlargement has been involved in the inhibition of 
complement-mediated phagocytosis (Zaragoza et al., 2003b). Capsule enlargement is 
achieved by the accumulation of newly synthesized polysaccharide in the capsule in a short 
period of time (Maxson et al., 2007a), suggesting that it is a high-energy cost process. 
Consequently, we hypothesized that capsule enlargement is a process that confers advantage 
to the fungus during the interaction with the host. The aim of this work was to examine 
whether capsule growth was associated with a higher resistance to some of the stress factors 
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that mimic the conditions that surrounds the fungal cells during its interaction with the host 
and phagocytic cells. Our results show that both capsular polysaccharide and capsule 
enlargement protects against a variety of stress conditions, implying a new mechanism that 
allows C. neoformans to survive and replicate inside macrophages.
Results
Killing by reactive oxygen species of cells with enlarged capsule in vivo and in vitro
We investigated whether capsular enlargement by C. neoformans conferred resistance to 
killing produced by reactive oxygen species (ROS). Cells with larger capsules were less 
susceptible to killing by ROS than cells with smaller capsules (Fig. 1, P-value at 3 h time 
point, 0.01). To investigate whether H2O2 carry-over to the agar plates had any influence in 
the results, we plated the sample (with and without hydrogen peroxide) at time zero and 
compared the viability and found no difference, indicating that H2O2 is diluted when the 
cells are plated. To exclude the possibility that H2O2 was affecting capsule size during the 
experimental conditions, we treated C. neoformans cells with large capsule with different 
H2O2 concentrations for 3 h, and measured for changes in the packed volume of the cells as 
described (Maxson et al., 2007a). The change in the packed volume of cells is an indirect 
measurement of the size of the capsule. We observed that even high H2O2 concentrations, 
such as 1 M H2O2, did not affect the packed volume of the cells during the 3 h incubation 
time (result not shown), indicating that in our conditions, H2O2 did not affect capsule size. 
This finding was confirmed by India Ink staining and microcopy observation. When we 
examined the effect at longer time periods, we observed that H2O2 killed cells with small 
and large capsule (result not shown).
Cells isolated directly from the lungs of infected mice during 18–24 h manifested enlarged 
capsules. After this short period of time, there is a significant increase in capsule size (result 
not shown). When we compared the susceptibility to H2O2 of cells from infected lungs and 
cells grown in regular Sabouraud medium, we observed that the cells recovered from mice 
were significantly more resistant to H2O2 than the cells grown in vitro (Fig. 2A) and this 
occurred even at a higher H2O2 concentration (2 mM, Fig. 2B). In fact, capsular 
enlargement that occurred in vivo was associated with higher resistance to killing by H2O2 
than capsule enlargement induced in vitro.
To confirm that the higher resistance observed in cells with enlarged capsule was directly 
due to a larger capsule size and not to higher catalase activity, we measured this enzymatic 
activity in our both types of cells, but found no difference (8.5 ± 2.6 mU per milligram of 
protein of enzymatic activity in cells with small capsule versus 10.2 ± 2 mU per milligram 
of protein in cells with enlarged capsule, P-value 0.4). However, in C. neoformans, it has 
been reported that the major enzymatic activity involved in ROS detoxification is 
gluthatione peroxidase (Brown et al., 2007). However, we could not detect this enzymatic 
activity (result not shown).
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Influence of capsular polysaccharide in killing of C. neoformans and Saccharomyces 
cerevisiae by H2O2
We hypothesized that cells with large capsule were less susceptible to free radicals than cells 
with smaller capsules through a ‘buffering mechanism’, whereby oxygen-derived oxidants 
attacked preferentially the polysaccharide fibres. Consequently we investigated whether 
purified capsular polysaccharide protected cells with small capsule from killing by H2O2. 
Cells with small capsules suspended in capsular polysaccharide had reduced susceptibility to 
killing by H2O2 compared with cells suspended in distilled water (Fig. 3A).
In a parallel approach, we investigated whether exogenous polysaccharide protected other 
fungal species, such as Saccharomyces cerevisiae, against ROS-induced killing. As shown 
in Fig. 3B, when H2O2 was added to cells in the presence of capsular polysaccharide, there 
was lower mortality than for cells suspended in water (Fig. 3B). To ascertain if there is a 
relationship between polysaccharide concentration and reduced killing, we performed a 
dose–response experiment. There was a decrease in the protection achieved below a 
polysaccharide concentration of 5 mg ml−1, and there was no statistical significant 
protection below 0.62 mg ml−1 (Fig. 3C).
Finally we investigated whether the protection observed would last during a longer 
incubation period. To address this issue, we incubated S. cerevisiae cells overnight in the 
presence of 0.5 mM H2O2 in a solution of capsular polysaccharide or in water as control. As 
shown in Fig. 3D, the cells remained viable after overnight exposure to H2O2 when capsular 
polysaccharide was present, and the survival rate was very similar to the one observed after 
2 h of incubation (see Fig. 3B).
To demonstrate that the capsule played a protective role against free radicals, we compared 
the survival of a wild-type encapsulated strain (B3501) and an acapsular mutant (cap59) 
when exposed to free radicals. As acapsular mutants aggregate, we could not perform the 
survival assay by counting the number of colony-forming units (cfu), so we decided to use 
the XTT reduction assay. Using this approach, the acapsular mutant had a higher 
susceptibility to H2O2 exposure than the wild-type strain (Fig. 3E). We confirmed this result 
by adding exogenous capsular polysaccharide to the acapsular strain. When the acapsular 
strain was exposed to H2O2 in the presence of capsular polysaccharide (10 mg ml−1), there 
was a significant increase in the survival of the strain (survival of cells suspended in water in 
the presence of H2O2, 15 ±2%; survival of the same cells treated the same way, but 
suspended in capsular polysaccharide 10 mg ml−1, 75 ± 2%), which is consistent with the 
data presented in Fig. 3A and B).
As soluble capsular polysaccharide protected C. neoformans and S. cerevisiae cells from 
killing by H2O2, we studied if it could behave as an antioxidant. Hence, we measured 
polysaccharide antioxidant ability using an assay in which electron transfer could be easily 
spectrophotometrically measured. The assay employed used the reduction of nitroblue 
tetrazolium (NBT) in the presence of β-nicotinamide adenine dinucleotide (NADH) and 
phenazine methosulfate (PMS) (Valentao et al., 2001; 2002; Ramallo et al., 2006). The 
addition of capsular polysaccharide affected the kinetics of NBT reduction in a dose-
dependent manner (Fig. 4A). This inhibition was calculated to be around 50% at 10 mg ml−1 
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and there was no inhibition below 2.5 mg ml−1 (Fig. 4B). This result con-firmed that the 
capsular polysaccharide could act as an antioxidant and suggests a mechanism by which 
capsule enlargement protects against ROS.
Effect of H2O2 on physical properties of the capsular polysaccharide
Zeta potential and mobility determinations of native capsular polysaccharide preparations 
(Table 1) revealed negative values. When the polysaccharide samples were exposed to 
higher H2O2 concentrations and for longer periods of time, we found an increase in both 
zeta potential and mobility values (Table 1).
The average effective diameter and size distribution of capsular polysaccharide samples 
treated with H2O2 were determined. Treatment with H2O2 reduced the effective diameter in 
the samples in a concentration-dependent manner (Table 1). Polydispersity and diffusion 
coefficients were also calculated (Table 1). We also analysed the size distribution of the 
different polysaccharide samples treated with different H2O2 concentrations, by using 
dynamic light scattering (see Experimental procedures). We found that there was a variation 
in the size distribution of the different polysaccharide preparations after treatment with 
H2O2 (Fig. 5). The polysaccharide not treated with H2O2 consisted of three major size 
distributions (321–465 nm, 1584–2291 nm and 7822–10 000 nm). When the polysaccharide 
was treated with 0.5 mM H2O2 there was a decrease in the proportion of larger molecules, 
with the two major distributions centred at 0–2311 nm and 5623–10 000 nm. Interestingly, 
when the polysaccharide was incubated overnight with the same H2O2 concentration, there 
was an intermediate distribution pattern (Fig. 5) showing two major size classes, at 275–293 
nm and 1788–2553 nm. In this condition, there were no fragments with a size bigger than 
4500 nm. We observed similar results treating the polysaccharide samples with a high H2O2 
concentration, such as 1 M (result not shown).
We also investigated whether ROS affected the binding of polysaccharide fibres to the cells. 
As stated above, 0.5 mM H2O2 did not affect capsule size. We tested if higher 
concentrations, such as 1 M, had any effect. We observed that 2 mM behaved in the same 
way as 0.5 mM. However, when cells with large capsule were exposed to high H2O2 
concentrations (1 M) for a longer time period (overnight) there was a significant reduction in 
the packed cellular volume (result not shown). This phenomenon was not observed at lower 
concentrations (0.5 and 2 mM), a finding confirmed by India Ink staining (result not shown). 
This effect was not observed in acapsular mutants, indicating that the decrease in cellular 
volume occurred at the capsule level.
Effect of capsule size in the activity of antimicrobial peptides and antifungal drugs
Cells with small capsule manifested a significantly higher susceptibility to defensins relative 
to cells with larger capsules (Fig. 6A). The effect was dependent on the defensin 
concentration. At higher defensin concentrations, the peptide killed both types of cells 
equally. The same result was obtained when viability was measured using the XTT assay. 
This result suggests that capsule enlargement confers resistance to microbicidal peptides of 
the type produced by phagocytes.
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We studied whether capsular enlargement protected against antifungal drugs. Although the 
minimum inhibitory concentration required to inhibit the growth of 90% of organisms 
(MIC90) was the same for both type of cells, we found that cells with enlarged capsule 
manifested reduced susceptibility to Amphotericin B compared with cells with smaller 
capsules at concentrations between 0.06 and 0.25 μg ml−1 (Fig. 6B). To ensure that once 
plated the cells were not affected by Amphotericin B, we plated cell samples at time zero, 
immediately after addition of the drug to the cell suspension. In these controls, no killing by 
Amphotericin B was observed, indicating that once plated, Amphotericin B is diluted on the 
plate and does not induce fungal death.
To test the role of the capsule in the susceptibility to other antifungal compounds which 
have a fungistatic (and not fungicidal) effect on C. neoformans, we measured the 
susceptibility of wild type (B3501) and isogenic acapsular mutant (cap59) to several 
antifungal drugs. As acapsular mutants clump in suspension, we could not use a 
microdilution reference method to measure the susceptibility pattern. So we decided to use 
E-test assay, which is performed in agar plates. Acapsular mutants were more susceptible to 
Amphotericin B, which is consistent with the findings obtained in Fig. 6B (Table 2). 
Concerning azole compounds, we did not find any significant difference between the strains, 
except for fluconazole. In this case, the MICs were higher in the wild-type strain than for the 
other azole derivatives, and we found that the acapsular strain was less susceptible to this 
compound. Both strains were resistant to caspofungin.
Capsule enlargement protects against engulfment by environmental predators
We investigated whether capsule enlargement protected against phagocytosis during its 
interaction with different hosts such as amoebas that efficiently phagocytose C. neoformans 
cells, without any requirement for opsonins. In these experiments, we incubated C. 
neoformans cells with Acathamoeba castellanii, and measured phagocytic index. In the 
initial experiments, we did not observe any phagocytosis, even using C. neoformans cells 
with small capsules. We considered whether the absence of phagocytosis in our control 
sample was due to the experimental conditions, in which the cells with small capsule were 
incubated in phosphate-buffered saline (PBS) as a control for the cells with large capsule, 
which were incubated in PBS + 10% fetal calf serum (FCS). To confirm that the incubation 
conditions affected the phagocytosis by amoeba, we grew cells in Sabouraud, placed them in 
PBS overnight, and then incubated them in Sabouraud for a short time (1 and 2 h). When the 
fungal cells were incubated back in Sabouraud, phagocytosis by amoeba increased, 
confirming that the pre-incubation conditions affected the phagocytosis percentage (Fig. 
7A). When the cells were incubated overnight in PBS + serum to induce capsule 
enlargement, and then placed again in Sabouraud for a short time period, capsule size was 
not affected (result not shown). With this experimental approach, we established that the 
cells with small capsule were efficiently phagocytosed as described previously (Steenbergen 
et al., 2001). However, cells with large capsule remained resistant to phagocytosis (Fig. 7B). 
Hence, capsule enlargement confers protection to phagocytosis by environmental hosts.
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Capsule enlargement is a distinctive feature of C. neoformans that is associated with 
virulence for mammalian hosts. This process is highly dynamic and is strictly controlled by 
the cell (Zaragoza et al., 2006). Nevertheless, the mechanism by which capsular 
enlargement contributes in virulence is not well understood. Although capsule growth is 
associated with a slower yeast growth rate (Zaragoza and Casadevall, 2004), this process 
requires a large accumulation of polysaccharide on the capsule (Maxson et al., 2007a), 
implying a high-energy-consuming process. One intriguing question about capsule 
enlargement is why, in conditions of a slow growth rate, the yeast invests a high amount of 
energy in enlarging the capsule. Consequently, we hypothesized that capsule growth must 
have positive consequences for the yeast during the interaction with the host. It is known 
that capsule enlargement interferes with complement-mediated phagocytosis (Zaragoza et 
al., 2003b). By enlarging the capsule, C. neoformans locates complement proteins in an 
internal position, where they cannot interact with the phagocytic complement receptors. 
However, interference with phagocytosis is unlikely to be the only role for capsule 
enlargement for several reasons. First, phagocytosis of C. neoformans cells with enlarged 
capsule can occur in the presence of opsonins, and even glucuronoxylomannan (GXM)–
CD18 interactions have been described, which promote phagocytosis in certain 
circumstances (Dong and Murphy, 1997; Netski and Kozel, 2002; Taborda and Casadevall, 
2002). Second, capsule enlargement occurs after several hours (6–9 h) (Zaragoza et al., 
2003a). As phagocytosis by alveolar macrophages can occur during the first 2 h of infection, 
it is reasonable to argue that capsule enlargement has other functions in virulence than 
simply interfering with engulfment by phagocytic cells.
Cryptococcus neoformans is an intracellular pathogen for mammalian phagocytic cells 
(Diamond and Bennett, 1973; Tucker and Casadevall, 2002) and environmental predators, 
such as amoebas (Steenbergen et al., 2001; 2003), which indicates that this pathogen has 
mechanisms that avoid killing by microbicidal factors found in the phagolysosome, which 
include oxygen- and nitrogen-derived free radicals, antimicrobial peptides, lytic enzymes 
and acidic pH. As a consequence of intra-cellular survival, C. neoformans can undergo 
intracellular replication and phagosome extrusion (Alvarez and Casadevall, 2006). Recently, 
it has been shown that cell-to-cell spread can also occur (Alvarez and Casadevall, 2007; Ma 
et al., 2007), reinforcing the idea that the intra-cellular environment is adequate for the 
survival of the yeast. We argued that capsule enlargement might play a role during this 
process, avoiding killing.
In agreement with our hypothesis, cells with enlarged capsules were more resistant to 
several stress factors that are likely to play a significant role in the phagolysosome, such as 
oxidative killing. In this regard, polysaccharides are known to be efficient free radical 
scavengers (Chan et al., 1991; Bylund et al., 2006) and protection against phagolysosomal 
oxidative burst would be a new function for the C. neoformans capsule in virulence. We 
found similar results in cells in which capsule size had been increased by passaging the cells 
through mice. It is reasonable to think that during the interaction with the host, in addition to 
capsule growth, other stress response pathways are activated that could explain in part the 
increased resistance of these cells. Although we cannot discard this possibility, our results 
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are suggestive of and consistent with the notion that capsule growth is directly involved in 
resistance to host cell microbicidal mechanisms. We are also aware that in our in vitro 
experimental approach, cells with different capsule size have been incubated in different 
media, which in turn could affect the metabolic and stress response pathways activated in 
the cells. However, we could not detect any difference in the activities of enzymes directly 
involved in free radicals detoxification. For this reason, and to confirm the direct role of the 
capsule as a detoxifying structure, we performed a set of experiments using purified capsular 
polysaccharide. We have shown that purified capsular polysaccharide produces the same 
effect as capsule enlargement, and moreover, it acts as an antioxidant in our in vitro assays. 
In most of the experiments of this study, we used a polysaccharide concentration between 5 
and 10 mg ml−1, and we observed that below these concentrations, there was a significant 
reduction in the protective effect. Previous findings report that the polysaccharide 
concentration in the capsule is approximately 6 mg ml−1 (Bryan et al., 2005), which 
indicates that the phenomena described in this article are potentially relevant to 
physiological conditions found during the interaction of the pathogen with the host. The 
molecular mechanism by which the capsular polysaccharide confers resistance to killing by 
H2O2 is unknown, but it is likely to reflect polysaccharide-mediated scavenging of oxygen-
related oxidants. A similar situation has been described for some polysaccharides isolated 
from plants and algae, which present antioxidant activity, and no relationship between 
structure and antioxidant mechanism has been identified (Ruperez et al., 2002; Kardosova 
and Machova, 2006; Wang et al., 2007; Kodali and Sen, 2008)
The notion that the C. neoformans capsular polysaccharide acts as an antioxidant by reacting 
and scavenging H2O2-derived products is supported by the fact that exposure to ROS altered 
several physical properties of the capsular polysaccharide, such as the zeta potential. The 
change in zeta potential values could be explained by a neutralization of the negative 
charges contributed by glucuronic acids, possibly through chemical modification of the 
polysaccharide. Hydrogen peroxide also affected the distribution of polysaccharide size in 
the samples and tended to enrich the population of low-size molecules, although the highest 
effect was observed only when the polysaccharide was exposed for a short time to the 
peroxide. Longer incubations could allow structural rearrangements that promote self-
association of the fibres. The fact that H2O2 changed the physical properties of the 
polysaccharide provides evidence for a reaction between these two entities. By increasing 
capsule size and the amount of polysaccharide in the capsule, the cell is presumably less 
susceptible to ROS through a buffering mechanism, so that free radicals would preferentially 
affect the capsule, leaving other cellular structures intact. This notion is consistent with the 
observation that encapsulated, but not acapsular cells replicate inside macrophages 
(Feldmesser et al., 2000a). In this sense, the capsule is not required for viability of the yeast 
(Chang and Kwon-Chung, 1994), which supports the idea that the effect of ROS on the 
polysaccharide fibres does not affect the survival of the C. neoformans cells. An interesting 
aspect of capsule and oxidant interactions is that free radicals can release the capsular 
polysaccharide, but only at high non-physiological concentrations, such as 1 M. This result 
suggests that the amount of polysaccharide accumulated in the cell could be sufficient to 
buffer physiological stress conditions. However, we noticed that some modifications found 
in the polysaccharide (Table 1) did not correlate with microscopic changes in capsule size. 
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Although this might appear at first glance as a discrepancy in the results, we believe that 
there are several explanations for these results. First, it is possible that fibres of a smaller 
size generated as a consequence of ROS action still retain the ability to self-associate and 
produce a capsule of similar size. The structural factors that result in the binding of the 
polysaccharide fibres between them and to the cell wall are unknown, so it is possible that 
some of the changes observed in soluble samples do not directly involve capsular decrease. 
However, a decrease in capsule size is not, in principle, a requirement to obtain a protective 
effect in the presence of free radicals. In addition, polysaccharide samples used in Table 1 
had been previously release from the capsule after γ-radiation treatment, which is an 
important experimental variation which makes the results not directly comparable. We 
believe that our results clearly demonstrate that free radicals can directly interact with 
capsular polysaccharide, which is a requirement for any antioxidant molecule.
In addition to free radicals, capsule growth decreased susceptibility to antimicrobial peptides 
and some antifungal drugs. Our results are in agreement with previous findings that 
suggested a role of the capsule in the defence against defensins (Alcouloumre et al., 1993). 
In the case of Amphotericin B, capsule enlargement produced an increase in the MIC50 
measured for cells with small capsule. Amphotericin B exerts its action through binding to 
ergosterol and pore formation in the cell membrane. Many factors, including charge 
repulsion and/or steric hindrance produced by the high cross-linking of the polysaccharide 
fibres, might play a role in protection against this large antifungal drug. We cannot discard 
that capsule size is associated with other cellular changes that decrease susceptibility to 
these factors, such as a different cell wall or membrane composition. In this context, changes 
in membrane structure in response to nutrient deprivation have been related to increased 
susceptibility to antimicrobial peptides in C. albicans (Veerman et al., 2007). Other recent 
reports indicate that in Aspergillus terreus, resistance to Amphotericin B is associated with 
higher catalase activity, which suggests that part of the killing effect of the antifungal drug is 
mediated through the production of free radicals that are detoxified by this enzyme (Blum et 
al., 2008). In this sense, and if Amphotericin B induces an oxidative burst in the cells that 
contributes to killing, cells with larger capsule could be more protected due to the increase 
in the synthesis of polysaccharide molecules that occurs in these conditions. The fact that C. 
neoformans cells with enlarged capsule show increased resistance to Amphotericin B 
suggests that the susceptibility pattern observed in vitro might not correlate with the 
Amphotericin B therapeutical effect during infection due to capsular morphological changes. 
In addition, capsule size during infection depends on the organ where the yeast is located 
(Rivera et al., 1998), suggesting that the efficacy of antifungal treatments against C. 
neoformans could vary depending on the organ where the yeast is preferentially infecting. 
Although the capsule conferred resistance to Amphotericin B, it did not have any effect in 
the cases of voriconazole, posaconazole and itraconazole, and moreover, the absence of the 
capsule conferred resistance to fluconazole. Interestingly, fluconazole is the only 
hydrophilic azole compound. As the capsule is also highly hydrophilic, it may facilitate the 
uptake of this compound and in turn increase the susceptibility to fluconazole. This result 
could have clinical significance because fluconazole is the maintenance treatment for HIV+ 
patients affected with cryptococcal meningitis, and infections produced by acapsular strains 
have been described (Lacaz et al., 1993; Laurenson et al., 1998). This suggests that in these 
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cases, a lack of response to fluconazole could be found. This finding could also explain the 
in vivo fluconazole resistance described in the literature (Assing et al., 2003; Sar et al., 
2004; Bicanic et al., 2006). The capsule did not play a role in the susceptibility to 
caspofungin, a drug to which C. neoformans has intrinsic resistance (Abruzzo et al., 1995; 
Feldmesser et al., 2000b).
Efficient phagocytosis and killing by mammalian cells depend on the binding of opsonins, 
as the capsule has antiphagocytic properties (Kozel and Gotschlich, 1982). Binding of 
monoclonal antibodies and/or serum to the capsule produces a partial blocking (Zaragoza 
and Casadevall, 2006), and we argued that in this case, opsonin binding might interfere with 
the killing produced by the antimicrobial factors. Consequently, we selected a phagocytosis 
model where no opsonins were required for ingestion. Amoebas efficiently engulf C. 
neoformans in the absence of opsonins (Steenbergen et al., 2001), and this interaction is 
considered highly relevant, because it suggests an explanation for the origin of virulence in 
this fungal species (Steenbergen and Casadevall, 2003; Steenbergen et al., 2003). The fact 
that capsule growth inhibited phagocytosis in this model highlights the importance that this 
process has in avoiding phagocytosis and killing by different types of hosts. Moreover, our 
results suggest that during the interaction with amoebas, capsule enlargement might allow 
the yeast to evade the immune response of metazoal hosts, such as mammals.
We also made the intriguing observation that when the cells were starved in PBS, they 
became resistant to phagocytosis. This result suggests that phagocytosis is affected not only 
by capsule size, but also by the environment of the fungal cell prior to interaction with 
amoeba. In this regard, there are reports in the literature that the incubation medium can 
affect some important features of the capsule, such as size and packing (Dykstra et al., 1977; 
Jacobson et al., 1989; Nimrichter et al., 2007). We believe that this observation is highly 
relevant in the context of the environmental relationships. It is reasonable to argue that in the 
areas where amoebas and fungal cells can interact, the situation resembles starvation, which 
would induce a capsule structure resistant to phagocytosis, independently of the size of the 
structure. So we hypothesize that this would be a persistent mechanism to avoid fungal 
phagocytosis in the environment.
In summary, we demonstrate that capsule enlargement is associated with reduced 
susceptibility to both oxidative and antifungal killing. As capsule enlargement occurs 
following infection and ingestion by macrophages, the results suggest an explanation for the 
inability of macrophages to kill this organism. We believe that some of the findings 
described in this study provide insights into the role of other type of microbial capsules, 
which is a common feature in bacterial pathogens, and in consequence, highlight its 
importance during the interaction with the host.
Experimental procedures
Strains, growth media and India Ink staining
Cryptococcus neoformans H99 strain (serotype A; Perfect et al., 1980) was used in most 
experiments, because previous studies have demonstrated that this strain efficiently 
modulates its capsule size depending on environmental conditions (Zaragoza et al., 2003a). 
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The wild-type strain B3501 (serotype D; Kwon-Chung, 1976) and the acapsular mutant 
C536 (Chang et al., 1995), and S. cerevisiae (ATCC 9763) were used in some experiments. 
The acapsular mutant was created by disruption of the CAP59 gene using B3501 as parental 
strain. The strains were routinely grown in liquid Sabouraud medium (Difco) at 30°C with 
moderate agitation. To induce capsule growth, the cells were transferred to PBS buffer with 
10% fetal bovine serum (Zaragoza et al., 2003a) or in diluted Sabouraud (10%) in MOPS 
buffer (50 mM, pH 7.3) at 37°C, with shaking (Zaragoza and Casadevall, 2004). In these 
media, C. neoformans produces a significant increase in capsule size, from 2–3 μm to 10–15 
μm. To visualize the size of the capsule, the cells were suspended in India Ink, and observed 
by regular light microscopy. A. castellanii (ATCC Strain 30324) was kindly provided by Dr 
Steinman (AECOM, Bronx, New York). The organisms were cultured in peptone-yeast 
extract-glucose broth, PYG (ATCC medium 354) in Falcon tissue culture flasks at 28°C. 
Amoeba cells were used when confluent on the bottom of the flask and were passaged every 
7–10 days.
Oxidative stress induced by H2O2
Cryptococcus neoformans cells with small and large capsules were washed and suspended in 
water at a density of 2 × 103 cells ml−1. Hydrogen peroxide was added at different 
concentrations and the cells were incubated at 37°C for different times. Controls included 
tubes without hydrogen peroxide incubated in parallel. Each sample was done by triplicate. 
Then, 50 and 100 μl were plated in Sabouraud plates, and incubated at 30°C for 2 days. The 
number of cfu was counted, and viability was expressed as the percentage of colonies 
obtained in the treated samples compared with the controls to which no H2O2 was added. 
The experiment was performed at least three times in different days. In some experiments, to 
test the role of the capsule as antioxidant, the cells were suspended in a solution of purified 
capsular polysaccharide (10 mg ml−1), and viability after H2O2 exposure was compared with 
samples suspended in distilled water.
XTT viability assay
In some experiments, XTT assay was used instead of cfu counting. C. neoformans cells 
(106) were placed in wells from microdilution plates (96-well plates), and H2O2 was added 
to different final concentrations. In some experiments, capsular polysaccharide to a final 
concentration of 10 mg ml−1 was also added. The total volume of the mixture was 100 μl. In 
all experiments, the same amount of dead cells (inactivated by incubating 30 min at 60°C) 
was included as negative controls. After incubating for 3 h, the plate was washed, and 100 μl 
of XTT 0.5 mg ml−1 in PBS containing menadione 25 μM was added in each well. The 
optical density at 492 nm was measured after 5–7 h of incubation at 37°C. Then, the optical 
density of the wells containing dead cells was subtracted from the optical density of each 
well, and the relative survival was compared in each sample compared with the well to 
which no H2O2 was added. Each treatment was performed in three different wells.
Capsule size changes measurement
Changes in capsule size were estimated by measuring the packed volume of the cells in the 
absence or presence or free radicals (see method in Maxson et al., 2007a). C. neoformans 
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cells with large capsule (around 108 ml−1) were suspended in distilled water and treated with 
different concentrations of H2O2 (0.5 and 2 mM and 1 M). A tube without any treatment 
was carried out in parallel as control. The samples were incubated for 3 h or overnight at 
37°C, and washed twice with distilled water and suspended in the same volume, having each 
sample the same cell density. Sixty microlitres from each suspension was placed inside a 
haematocrit tube. After overnight packing of the cells by gravity, the volume occupied by 
the cells was calculated (Maxson et al., 2007a).
γ-Radiation and capsule isolation
Capsular polysaccharide was obtained as in Maxson et al. (2007b) with some modifications. 
Briefly, capsule enlargement was induced at a large scale (around 109−1010 cells in at least 1 
l of 10% Sabouraud medium in MOPS 50 mM, pH 7.3), and cells were extensively washed 
and suspended in distilled water. The cells were heat-inactivated by incubating them at 55°C 
for 30 min, then placed in a 137Cs γ-irradiator (MARK 1–30 irradiator, Shepherd and 
Associates), and irradiated. A dose of 200 greys effectively released more than 90% of the 
capsule from the cells, and this dose was routinely used in our experiments. The γ-irradiator 
belonged to the National Center for Biotechnology (CSIC, Madrid, Spain), and its use was 
preceded by the approval from the Biosafety Commission from this institution. After 
irradiation, the cells were centrifuged at 3500 g, and the supernatant was transferred to a 
new tube. The polysaccharide was lyophilized, weighted and suspended in sterile water at 10 
mg ml−1. The soluble capsular polysaccharide obtained through this protocol was heated 
again at 55°C for 30 min to eliminate remaining C. neoformans cells.
NBT reduction assay in the presence of NADH and PMS. Antioxidant role for capsular 
polysaccharide
To test the antioxidant role of the capsular polysaccharide we used the NBT reduction assay 
coupled to NADH and PMS (Valentao et al., 2001; 2002; Ramallo et al., 2006). In this 
system, NADH is oxidized by transferring electrons to PMS, which acts like an electron 
transfer intermediate, able to reduce NBT molecules. NBT reduction can be easily 
monitored by absorbance measurement at 540 nm. Briefly, the reaction was performed in 
96-well plates using 250 μl per assay. Each sample contained phosphate buffer (40 mM, pH 
7.6), NADH (166 μM) and NBT (43 μM). The mix was incubated for 2 min at room 
temperature and NBT reduction was started by the addition of 2.7 μM PMS. One parallel 
well to which no PMS was added was left as a control. All the reagents were freshly 
prepared at a 10× concentrated stock, except the buffer, which was prepared at 5×. The plate 
was immediately placed in an iEMS Reader MF (Lab-Systems, Finland) and incubated at 
37°C. Optical density was monitored every 30 s during 30 min. Each condition was 
performed in two independent replicate wells. In some assays, capsular polysaccharide at 10, 
5, 2.5 and 1.25 mg ml−1 was added to the wells. The antioxidant efficacy of the 
polysaccharide was estimated by calculating the relative decrease in the NBT reduction 
compared with the controls to which no polysaccharide was added.
Zaragoza et al. Page 12













Zeta potential and dynamic light scattering analysis of H2O2-treated polysaccharide 
samples
Capsular polysaccharide was obtained from C. neoformans after γ-irradiation treatment as 
described above. Parallel samples containing 4 mg in 1 ml of distilled water were treated 
with H2O2 (0.5 mM or 1 M) for 2 h or overnight at 37°C. After the treatment, the samples 
were dialysed in water overnight and then lyophilized. The samples were suspended at 1 mg 
ml−1 in ultrapurified water. Effective diameter and polydispersity of all the capsular 
polysaccharide samples were measured by Quasi elastic light scattering in a 90Plus/BI-MAS 
Multi Angle Particle Sizing analyser (Brookhaven Instruments, Holtsville, NY) following 
the manufacturer’s recommendations. We used non-H2O2-treated polysaccharide as control. 
Size distribution of the particles was calculated based on Non-Negatively constrained Least 
Squares (NNLS) algorithm. The results show average of 20 runs (Frases et al., 2008). Zeta 
potential and mobility were measured using a Zeta potential analyser (Zeta-Plus, 
Brookhaven Instruments, Holtsville, NY) following the manufacturer’s recommendations 
(Nosanchuk and Casadevall, 1997; Maxson et al., 2007b). The results show the average of 
20 runs. Zeta potential is defined as the potential gradient (mV) that develops across the 
interface between a boundary liquid in contact with a solid and the mobile diffuse layer in 
the body of the liquid. The mobility is the velocity of the particles moving to an electrode of 
the opposite charge when an electric field is applied.
Killing by antimicrobial peptides
Defensin PG-1 (Lehrer and Ganz, 1996) was kindly provided by Dr Nosanchuk. This short 
peptide has anticryptococcal activity (Doering et al., 1999; Martinez and Casadevall, 2006). 
Cells with small and large capsule were washed with PBS and suspended in the same buffer 
at 103 cells ml−1 with different concentrations of Defensin PG-1 and incubated at 37°C for 
30 min. Controls included parallel samples without defensins. After incubation with and 
without defensin, the number of cfu was determined by plating 100 μl on Sabouraud’s agar. 
The experiment was performed three times on three different days.
Mouse infection and isolation of fungal cells from infected mice
To obtain cells with large capsule induced under physiological conditions, we infected CD1 
mice (male, around 25 g weight, Charles River Laboratories) with 5 × 107C. neoformans 
cells. Briefly, C. neoformans (H99 strain) was grown in liquid Sabouraud medium (20 ml), 
washed with PBS and suspended at 109 cells ml−1. Fifty microlitres from this suspension 
was injected intratracheally in the mice. After 18–24 h, the mice were sacrificed by cervical 
dislocation, and the lungs were isolated and homogenized in 10 ml of PBS containing 
collagenase A (1 mg ml−1). The homogenate was incubated at 37°C for 90 min with 
occasional shaking (vortex), and after this time, the cells were extensively washed (at least 
five times) with 30 ml of distilled water. The cells were finally suspended in 2–5 ml of 
water, and counted with a haemocytometer. This protocol gave a clean C. neoformans 
preparation, as ascertained by microscopic examination of the suspension. The cells density 
was adjusted to 103 cells ml−1, and H2O2 was added as described above. As control, cells 
incubated in Sabouraud were exposed to the same H2O2 concentration in parallel.
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Cell-free protein extract preparation and catalase and gluthatione peroxidase activity 
assay
Catalase activity was measured according to Aebi (1984) with some modifications. Briefly, 
cells with small and large capsule were obtained from 25 ml of the corresponding medium 
(Sabouraud or diluted Sabouraud in MOPS buffer). The cells were collected by 
centrifugation, and kept at −20°C until the activity was measured. To prepare protein cell-
free extracts, the cells were thawed in 0.5 ml of imidazole buffer (20 mM, pH 7) at 4°C, and 
the cells were broken by vigorous vortexing after addition of 1 g of glass beads (0.5 mm 
diameter). The homogenates were centrifuged and supernatants were transferred to clean 
micro-centrifuge tubes. The catalase reaction mixture (500 μl final volume) contained 
phosphate buffer (50 mM KH2PO4, pH 7) and 20 mM H2O2. After stabilization of the 
absorbance at 260 nm, the reaction involved the measurement of catalase activity by the 
addition of 25 or 50 μl of the protein cell-free extract to the reaction mixture. The enzymatic 
activity was expressed in units, defined as the amount of enzyme necessary to hydrolyse 1 
μmol of H2O2 in 1 min. Protein concentration was measured with the biocinchoninic acid 
(BCA) protein assay kit (Pierce), using bovine serum albumin (BSA) as standard and 
enzymatic activity was normalized by the protein concentration in each sample. Gluthatione 
peroxidase was measured as described in Veal et al. (2002).
Amphotericin B-induced killing assay
Cells with small and large capsules (obtained as described above) were washed and 
suspended in distilled water at a cell density of 2 × 103 ml−1. One hundred microlitres from 
this suspension were added to 96-well plates containing 100 μl of 2 × RPMI medium 
buffered with MOPS at pH 7 containing different concentrations of Amphotericin B, ranging 
from 16 to 0.032 μg ml−1. The last two wells in each row did not contain antifungal drug, 
and they were used as control. After addition of the cells, the plate was incubated at 30°C for 
3 h with shaking 5 min every hour at 1320 r.p.m. Then 100 μl from each well was directly 
plated in Sabouraud plates and incubated at 30°C for 2 days. Viability was calculated as 
described above. The experiments were performed in triplicate and they were performed 
several times in different days.
Antifungal susceptibility testing using E-test assay
E-test strips (amphotericine B, voriconazole, fluconazole, itraconazole, posaconazole and 
caspofungin) were supplied by AB Biodisk (Stockholm, Sweden). The yeast inoculum was 
adjusted with a spectrophotometer by adding sterile 0.85% NaCl to match the transmittance 
that was produced by a 0.5 McFarland standard at 530 nm. A volume of 240 μl was spread 
on Sabouraud plates and these plates were let to dry before the strips were applied. The 
MICs were read after 48 h of incubation at 30°C. The MIC was read as the lowest 
concentration at which the border of the elliptical inhibition zone intersected the scale on the 
strip. Microcolonies inside the inhibition zone were ignored.
Phagocytosis of C. neoformans by amoeba
Confluent A. castellanii cells, grown as described above, were removed from culture flasks 
and counted. The cells were suspended in PBS, and after plating 106 cells per well in 96-
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well plates, they were allowed to adhere at 28°C for 1 h. During this time, C. neoformans 
cells with different capsule size were also washed, counted and suspended in PBS. Once 
amoebas adhered to the plate, C. neoformans cells were added and co-incubated with A. 
castellanii cells at 28°C (incubation time dependent on experiment). Plates were then 
removed from the incubator, centrifuged to sediment A. castellanii to the bottom of the plate 
and the supernatant was removed by aspiration. One hundred microlitres of ice-cold 
methanol were added to each well, and plates were incubated at 4°C for 30 min. Methanol 
was then removed and PBS was added twice to wash the wells. For staining of A. castellanii 
cells, a 1:20 dilution of Giemsa was added for 30 min. After rinsing twice with PBS, the 
plates were viewed at 40× and counted to determine the phagocytic index. The phagocytic 
index is defined as the number of A. castellanii with internalized yeast per total amoeba cells 
counted as a percentage. For the determination of phagocytic index approximately 100 cells 
were counted in 6–10 wells in each condition.
Statistics
Differences in fungal survival were analysed using t-test, after assaying normality using the 
Kolgomorov–Smirnoff test using the Unistast software for Excel (Unistat, London, UK).
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C. neoformans cells differing in capsule size manifest different susceptibility to H2O2. C. 
neoformans cells with small and large capsule (induced in diluted Sabouraud in MOPS 
buffer) were incubated with 0.5 mM H2O2 at 37°C. Parallel samples not exposed to H2O2 
were carried out in parallel. At the indicated times, 100 μl aliquots were plated in 
Sabouraud, and viability was calculated at each time point as described in Experimental 
procedures. Solid line, small capsule; dotted line, cells with large capsule. At each time, the 
mean value and standard deviation of the viabilities from four different experiments are 
plotted. Asterisk indicates statistical differences at the time point indicated (P < 0.05).
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Susceptibility of C. neoformans cells isolated from mice to H2O2. Cells with enlarged 
capsule were obtained from the lungs of infected mice as described in Experimental 
procedures. The cells were exposed to 0.5 mM (A) or 2 mM (B) H2O2, and survival was 
monitored as in (A) and as described in Experimental procedures. Open bars, cells grown in 
Sabouraud; closed bars, cells obtained from mice. Asterisks indicate statistical differences 
between cells grown in Sabouraud or isolated from infected mice, and the corresponding P-
value is shown.
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Purified capsular polysaccharide protects C. neoformans and S. cerevisiae. Purified capsular 
polysaccharide was obtained from cells with enlarged capsule by γ-irradiation as described 
in Experimental procedures. This polysaccharide was lyophilized and dissolved at 10 mg 
ml−1 (A and B) in distilled water. Cells from C. neoformans (A) or S. cerevisiae (B–D) were 
grown in Sabouraud, washed, and suspended in distilled water or capsular polysaccharide.
A and B. H2O2 0.5 mM was added to both samples (closed bars), and parallel samples to 
which no H2O2 was added were carried out in parallel (open bars). Viability was measured 
after 2 h of incubation at 37°C. Asterisk denotes statistical differences (P < 0.01).
C. Dose–response protection, using S. cerevisiae. Serial dilutions of the capsular 
polysaccharide were prepared (from 10 to 0.08 mg ml−1), and S. cerevisiae cells were added 
to each suspension. H2O2 (0.5 mM) was added to these samples. As controls, we included 
H2O2-treated and non-treated samples suspended in distilled water (left and right bars). 
Viability was measured after 2 h of incubation at 37°C. The experiment was performed in 
triplicates. In all the panels, the survival mean value and the standard deviation are plotted. 
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Asterisk denotes statistical differences with the control where the cells were treated with 
H2O2 suspended in water (right bar).
D. Cells were treated as in (B), but plated after 24 h of incubation and pictures of the plates 
of the different samples were taken.
E. Cells from the wild-type strain (B3501) and the acapsular mutant (C536, cap59 
disruptant) were placed in triplicates in wells from microdilution plates (106 cells per well, 
approximately) in the presence or absence of 0.5 mM H2O2. After 3 h incubation, the wells 
were washed, and XTT/menadione mixture was added to each well. Viability was calculated 
as Experimental procedures. Closed bars, controls without H2O2; open bars, 2 mM H2O2.
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Capsular polysaccharide affects NBT reduction in the NADH/PMS electron transfer system. 
NBT reduction induced by NADH and PMS was monitored by measuring absorbance at 540 
nm in the absence or presence of different concentrations of capsular polysaccharide.
A. Optical density (O.D.) increase during 30 min.
B. Inhibition percentage of NBT reduction in the presence of different polysaccharide 
concentrations.
The experiment was performed in duplicates, obtaining almost identical results (P < 0.05).
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Reactive oxygen species affect the size of the polysaccharide molecules. The distribution of 
the molecular size of polysaccharide samples was measured after treatment with 0.5 mM 
H2O2 during 2 h or overnight at 37°C as described in Experimental procedures.
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Fig. 6. C. neoformans cells manifest different susceptibility to antimicrobial agents depending on 
their capsule size
A. Cells with small and large capsule were exposed to different defensin concentrations, and 
after 30 min, viability was estimated by plating 100 μl on Sabouraud plates. The mean value 
and standard deviation from three different experiments are plotted. Solid line, cells with 
small capsule; dotted line, cells with large capsule. Asterisk denotes statistical differences 
between cells with small and large capsule at the defensin concentration indicated.
B. Cells with small and large capsule were exposed to different Amphotericin B 
concentrations during 3 h at 37°C, and viability was estimated by cfu enumeration as 
described in Experimental procedures. The average and the standard deviation of four 
different experiments are plotted. Solid line, cells with small capsule; dotted line, cells with 
large capsule. Asterisk denotes statistical differences between cells with small and large 
capsule at the Amphotericin B concentration indicated (P = 0.05).
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Fig. 7. C. neoformans cells with different capsule size manifest differences in susceptibility of 
phagocytosis by A. castellanii
A. C. neoformans cells were incubated overnight in PBS, and then transferred to Sabouraud 
or PBS for 1 or 2 h. Afterwards the cells were washed and used in phagocytosis experiments 
in the presence of A. castellanii as described in Experimental procedures. The mean value 
and standard deviation of three different experiments are shown. Statistical differences 
between samples are highlighted with arrows, and the P-value of the comparison is shown.
B. C. neoformans cells were incubated overnight in PBS or in PBS + 10% FCS or in 
Sabouraud, and then transferred to Sabouraud, PBS or PBS + 10% FCS for 2 h. Each bar is 
labelled first with the condition in which the cells were placed overnight and then with the 
condition in which they were placed for 2 h. The experiment was performed in triplicate, 
and the mean value and standard deviation are shown. Statistical differences between 
samples are highlighted with arrows, and the P-value of the comparison is shown.
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Table 2
Susceptibility profile of wild-type and acapsular strains to antifungal compounds.
MICs (mg l−1)
Wild type cap59




Fluconazole 4/3 64/> 256
Caspofungin > 32/> 32 > 32/> 32
The minimal inhibitory concentration (MIC, mg l−1) for a variety of antifungal compounds was calculated for the wild-type (B3501) and acapsular 
strain (C536, cap59 disruptant) using E-test assay as described in Experimental procedures. The experiment was performed in duplicate in different 
days, and the MIC values obtained in both experiments are presented.
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